Chemical Radiosensitizers: The Journal History.

CONCLUSION: The development of an agent that would differentially sensitize tumors to irradiation remains a "holy grail" of clinically-oriented radiobiology. Approaches to this goal have been a major feature of the Journal since its first decade, but we have yet to find such an agent. Perhaps we should be discouraged, but personally I remain optimistic that we (or our students) will succeed. PMID: 30657352 [PubMed - as supplied by publisher]
Source: International Journal of Radiation Biology - Category: Radiology Tags: Int J Radiat Biol Source Type: research